FDA Issues Warning Letter to Seatex
May 22, 2024
May 22, 2024
WASHINGTON, May 22 -- The U.S. Department of Health and Human Services' Food and Drug Administration issued the following warning letter to Seatex LLC:
* * *
To: Jonathan P. O'Dwyer, President and CEO, Seatex, LLC, 445 Texas Highway 3,6 Rosenberg, TX 77471, United States
Dear Mr. O'Dwyer:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, Seatex, LLC, FEI: 3007709579, at 445 Texas Highway 36, Rosenberg, Texa . . .
* * *
To: Jonathan P. O'Dwyer, President and CEO, Seatex, LLC, 445 Texas Highway 3,6 Rosenberg, TX 77471, United States
Dear Mr. O'Dwyer:
The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, Seatex, LLC, FEI: 3007709579, at 445 Texas Highway 36, Rosenberg, Texa . . .